Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
Sales | 900 | 0 | 0 | 0 | 0 |
Gross Profit | 900 | N/A | N/A | N/A | N/A |
Operating Expenses | 5,520 | 6,172 | 5,889 | 5,770 | 4,972 |
Operating Income | -4,620 | -6,172 | -5,889 | -5,770 | -4,972 |
Interest Expense | 0 | 0 | 0 | 2 | 0 |
Other Income | 9 | -65 | -39 | 1 | 23 |
Pre-tax Income | -4,611 | -6,238 | -5,928 | -5,771 | -4,949 |
Net Income Continuous | -4,611 | -6,238 | -5,928 | -5,771 | -4,949 |
Net Income | $-4,611 | $-6,238 | $-5,928 | $-5,771 | $-4,949 |
EPS Basic Total Ops | -0.33 | -0.50 | -0.51 | -0.56 | -0.49 |
EPS Basic Continuous Ops | -0.33 | -0.50 | -0.51 | -0.56 | -0.49 |
EPS Diluted Total Ops | -0.33 | -0.50 | -0.51 | -0.56 | -0.49 |
EPS Diluted Continuous Ops | -0.33 | -0.50 | -0.51 | -0.56 | -0.49 |
EBITDA(a) | $-4,605 | $-6,155 | $-5,871 | $-5,752 | $-4,954 |